Team
We’ve worked hard to build a talented specialist Healthcare focused team that knows the industry, its people and the M&A market. We pride ourselves on providing independent, insightful, high quality advice to SMEs, investors and entrepreneurs, as well as private equity firms and venture capital firms.
Gordon Hamilton, Managing Director
Gordon founded Alpha Helix after buying out Nexus Corporate Finance from the Nexus Group. Gordon has over twenty years' experience advising healthcare companies, both public and private, domestic and international on a range of transactions and financial products.
Sam Rolls, Director
Sam is responsible for assisting with all aspects of deal delivery. He previously worked for Darwin Alternatives, an alternative investment fund. He is a certified CFA charterholder and has also passed the IMC exams.
Bettina Salomon, Associate
Bettina joined Alpha Helix as an analyst in September 2019. She is responsible for assisting Gordon with deal coordination. Prior to joining Alpha Helix, Bettina was an intern at Nexus Investments.
Steve Travers, Consultant
Steve joined the Alpha Helix team as a Consultant in February 2021 having had a successful executive level career in the healthcare services sector for almost 15 years.
Matthew McKechnie, Analyst
Matthew performs research, analysis, and financial modelling for Alpha Helix. He holds a BBusSci (Honours) degree specialising in Finance and an MCom in Risk Management of Financial Markets from the University of Cape Town. Matthew has passed all 3 levels of the CFA® programme.
Azhar Kahn, Analyst
Azhar performs research, analysis, and financial modelling for Alpha Helix. He previously worked at Vodacom Group in South Africa for two years. He holds a BBusSci (Honours) degree specialising in Finance from the University of Cape Town.
Welcome to Alpha Helix
We are pleased to announce that on 12th March of this year, Gordon Hamilton led the MBO of Nexus Corporate Finance (NCF), therefore we have re-branded as Alpha Helix Corporate Finance (AHCF).
The team will remain unchanged and will continue to provide independent advice to exciting and fast-growing UK SMEs in the Healthcare sector.